sees fy 2020 sales $2.035 billion to $2.055 billion.
q2 sales $527.2 million versus refinitiv ibes estimate of $496.1 million.
raising full-year 2020 adjusted-diluted earnings per share guidance to a new range of between $4.15 and $4.25.
west pharmaceutical services - net sales guidance includes estimated full-year headwind of $26 million for 2020 based on current foreign exchange rates.
